New 4-Drug cocktail aims to tame tough liver cancer
NCT ID NCT07350070
First seen Jan 26, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tests a new combination of four treatments for people with liver cancer that cannot be removed by surgery and who also have high blood pressure in the liver (portal hypertension). The goal is to see if adding a blood pressure drug (carvedilol) to standard cancer therapies (TACE, immunotherapy, and a targeted drug) can improve tumor shrinkage and keep the disease under control. About 78 adults aged 18-75 with newly diagnosed liver cancer will take part. The approach is not a cure, but aims to manage the cancer and protect the liver.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology
Fuzhou, Fujian, China
Contact Email: •••••@•••••
-
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Contact Email: •••••@•••••
-
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hubei Province Tahe Hospital
Taihe, Hubei, China
Contact
-
Organ Transplant Department,Qilu Hospital, Cheeloo College of Medicine, Shandong University,
Jinan, Shandong, 250012, China
Contact Email: •••••@•••••
-
Qingdao University Affiliated Hospital
Qingdao, Shandong, China
Contact
-
Shandong First Medical University Affiliated Provincial Hospital
Jinan, Shandong, China
Contact
Conditions
Explore the condition pages connected to this study.